| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Paeonol | Bladder Cancer | 1 | PM | 32691366 | 📋 | Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo |
| Paeonol | Cancer | 2 | PM | 37544285 | 📋 | Paeonol repurposing for cancer therapy: From mechanism to clinical translation |
| Paeonol | Cancer | 1 | PM | 37408762 | 📋 | Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy |
| Paeonol | Cervical Cancer | 2 | PM | 33786614 | 📋 | Paeonol prevents migration and invasion, and promotes apoptosis of cervical cancer cells by inhibiting 5‑lipoxygenase |
| Paeonol | Cervical Cancer | 1 | PM | 33710373 | 📋 | Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway |
| Paeonol | Gastric Cancer | 1 | PM | 35026514 | 📋 | Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis |
| Paeonol | Lung Cancer | 2 | PM | 38265681 | 📋 | Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells |
| Paeonol | Lung Cancer | 1 | PM | 34636432 | 📋 | Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR-126-5p/ZEB2 axis |
| Paeonol | Melanoma | 1 | PM | 36958259 | 📋 | Paeonol inhibits melanoma growth by targeting PD1 through upregulation of miR-139-5p |
| Paeonol | Ovarian Cancer | 1 | PM | 38345445 | 📋 | Paeonol impacts ovarian cancer cell proliferation, migration, invasion and apoptosis via modulating the transforming growth factor beta/smad3 signaling pathway |
| Paeonol | Pancreatic Cancer | 1 | PM | 32099461 | 📋 | Paeonol Inhibits Pancreatic Cancer Cell Migration and Invasion Through the Inhibition of TGF-β1/Smad Signaling and Epithelial-Mesenchymal-Transition |
| Paeonol | Renal Cell Carcinoma | 1 | PM | 34813895 | 📋 | Investigation on the antitumor effects of paeonol against renal cell carcinoma based on network pharmacology and experimental validation |
